Agenus | AGEN - Trade Debtors


Agenus reported $22.44M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Agenus USD 22.44M 1.14M Dec/2025
Amgen USD 9.14B 432M Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Celldex Therapeutics USD 2.02M 1.92M Dec/2025
CSL USD 4.32B 1.35B Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Glaxosmithkline GBP 10.45B 707.81M Dec/2025
Incyte USD 1.05B 27.09M Mar/2026
Intrexon USD 1.02M 559K Jun/2024
J&J USD 21.33B 3.72B Dec/2025
Jiangsu Hengrui CNY 6.51B 569.71M Mar/2026
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
MacroGenics USD 13.37M 55.86M Dec/2025
Merck EUR 4.44B 293M Dec/2025
Merck USD 11.78B 345M Dec/2025
Northwest Biotherapeutics USD 311K 299K Sep/2025
Novartis USD 9.6B 2.69B Mar/2026
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 15.84B 2.27B Dec/2025
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Veracyte USD 44.66M 3.17M Dec/2025